Petal Surgical
"Acoustic Liquefaction Surgery"
Petal Surgical develops an incisionless surgical robotic platform using focused-ultrasound Acoustic Sculpting to destroy tissue without cuts or heat.
Petal Surgical is a surgical technology company based in Redwood City, California, founded in 2021 and co-founded by Prash Chopra, a veteran of surgical robotics companies Intuitive Surgical and Verb Surgical. The company is pioneering incisionless surgery through its proprietary Acoustic Sculpting technology, a form of boiling histotripsy that uses focused sound waves to precisely destroy harmful tissue without cuts, heat, or toxicity.
Petal's platform integrates acoustic liquefaction with robotics, imaging, and AI-driven controls to deliver precise, reproducible tissue treatment using Millisecond Pulse Histotripsy, aiming to create an outpatient-ready standard of care that avoids the trauma of conventional and minimally invasive surgery. The company emerged from stealth in October 2025 with a $10 million Series A round and has raised over $25 million in total financing, with participation from investors including Draper Associates, Actions Capital (formerly K50 Ventures), and the Fong's Family Foundation. Surgical robotics pioneer Fred Moll, co-founder of Intuitive Surgical, has joined the company's board. Petal Surgical's leadership team brings expertise spanning neurosurgery, medical robotics, and advanced energy systems, positioning the company to advance focused-ultrasound robotic therapy in the medical device sector.
Primary type & automation activities this supplier delivers:
Contact Petal Surgical
WEBSITE
https://www.petalsurgical.com/HEADQUARTERS
United States
Company Facts
Founded
2021
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
Early-Stage VC
Funding Total
-
Certifications & Memberships
Petal Surgical adds more funding for incisionless surgical robot
Petal Surgical has announced additional funding to enhance its innovative incisionless surgery method, which aims to revolutionize surgical care. This advanced technique is designed to make treatments safer, more accessible, and less traumatic for patients globally. The company believes that this approach could set a new standard in the medical field, potentially transforming the way surgeries are performed. The funding will support the development and deployment of their surgical robot, furthering their mission to improve patient outcomes and expand the reach of advanced surgical options.
Financial Healthcare Robotics Investments Markets / Industries News Surgical / Interventional Systems
